ZA898936B - Use of benzomorphanes for cytoprotection - Google Patents

Use of benzomorphanes for cytoprotection

Info

Publication number
ZA898936B
ZA898936B ZA898936A ZA898936A ZA898936B ZA 898936 B ZA898936 B ZA 898936B ZA 898936 A ZA898936 A ZA 898936A ZA 898936 A ZA898936 A ZA 898936A ZA 898936 B ZA898936 B ZA 898936B
Authority
ZA
South Africa
Prior art keywords
benzomorphanes
cytoprotection
Prior art date
Application number
ZA898936A
Other languages
English (en)
Inventor
Adrian Carter
Carter Adrian
Helmut Ensinger
Ensinger Helmut
Herbert Merz
Merz Herbert
Enzio Mueller
Mueller Enzio
Werner Stransky
Stransky Werner
Gerhard Walther
Walther Gerhard
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ZA898936B publication Critical patent/ZA898936B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA898936A 1988-11-24 1989-11-23 Use of benzomorphanes for cytoprotection ZA898936B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3839659A DE3839659A1 (de) 1988-11-24 1988-11-24 Verwendung von benzomorphanen zur zytoprotektion

Publications (1)

Publication Number Publication Date
ZA898936B true ZA898936B (en) 1991-07-31

Family

ID=6367798

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA898936A ZA898936B (en) 1988-11-24 1989-11-23 Use of benzomorphanes for cytoprotection

Country Status (7)

Country Link
EP (1) EP0370499A3 (ja)
JP (1) JPH02193922A (ja)
CA (1) CA2003572A1 (ja)
DE (1) DE3839659A1 (ja)
DK (1) DK589089A (ja)
HU (1) HUT55231A (ja)
ZA (1) ZA898936B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4222092A1 (de) * 1992-07-06 1994-01-13 Miele & Cie Backofen mit einem Kühlluftgebläse und/oder mit einem Heißluftgebläse
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
EP1005348A1 (en) 1996-09-27 2000-06-07 Guilford Pharmaceuticals Inc. Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
DE19907874A1 (de) * 1999-02-23 2000-08-24 Boehringer Ingelheim Pharma N-(5-Phenyl-tetrahydrofuranyl)methyl- und N-(6-Phenyl-tetrahydropyranyl)methyl substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TW201431842A (zh) * 2012-11-09 2014-08-16 Purdue Pharma Lp 苯並嗎啡烷類似物及其應用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS166803B2 (ja) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
DK589089A (da) 1990-05-25
CA2003572A1 (en) 1990-05-24
HUT55231A (en) 1991-05-28
JPH02193922A (ja) 1990-07-31
DK589089D0 (da) 1989-11-23
EP0370499A2 (de) 1990-05-30
DE3839659A1 (de) 1990-05-31
HU896152D0 (en) 1990-02-28
EP0370499A3 (de) 1991-06-05

Similar Documents

Publication Publication Date Title
BG51041A3 (en) Process for the preparation of (s)- alpha- ethyl- 2- oxo- 1- pyrrolidineacetamide
GB2205745B (en) Use of dioxopiperidine derivatives as analgesics
HU895849D0 (en) Process for the preparation of 1-threonine
IL92437A0 (en) Preparation of n-acyl-aminomethylphosphonates
ZA898936B (en) Use of benzomorphanes for cytoprotection
EP0365970A3 (en) Process for the preparation of cyclopropanamide
BG50834A3 (en) Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides
GB2213505B (en) Tape for technical use
GB2251402B (en) Procedure for the manufacture of contour-stable objects
GB2225113B (en) State of fill-determining apparatus
GB2217729B (en) Obtenation of scualane
GB8802421D0 (en) Set of parts
GB2217707B (en) Process for the preparation of acryloyloxyethoxymethyl-melamines
EP0324336A3 (en) Process for the preparation of 3-cyano-4-aryl-pyrroles
GB2224026B (en) Process for the preparation of 3-phenoxybenzylalcohol
GB8809272D0 (en) Attachment for used can
GB2219583B (en) Process for the preparation of dibromomethane
YU16389A (en) Aminoketons of substituted dibenzo- and pyrido benzoazepines
IL90302A0 (en) Process for the preparation of 2-alkylpyrimidines
ZA899519B (en) Process for the preparation of perhaloalkylthioethers
IE882090L (en) New use of 5-ht3-antagonists
GB8810810D0 (en) New use
IE893743L (en) Use of benzomorphans for cytoprotection
ZA884990B (en) New use of 5-ht3-antagonists
PL276489A1 (en) Method for preparation of the developed polyesthroles